SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SELLAS Life Sciences Q3 EPS $(2.68) Vs. $(26.75) YoY

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(2.68) per share. This is a 89.98 percent increase over losses of $(26.75) per share from the same period last year.

Benzinga · -

SELLAS Life Sciences (NASDAQ:SLS) reported quarterly losses of $(2.68) per share. This is a 89.98 percent increase over losses of $(26.75) per share from the same period last year.